Literature DB >> 2661286

Reciprocal allogeneic bone marrow transplantation between NOD mice and diabetes-nonsusceptible mice associated with transfer and prevention of autoimmune diabetes.

D M LaFace1, A B Peck.   

Abstract

Reciprocal allogeneic bone marrow transplantations were carried out between diabetes-susceptible nonobese diabetic (NOD) and diabetes-nonsusceptible C57BL/6 or B10.BR/cd mice to examine the role of the immune system and host environment in the development of autoimmune diabetes. Serotyping of lethally irradiated hosts reconstituted with allogeneic bone marrow showed the hematopoietically derived cells to be of donor origin. Our results showed that lethally irradiated NOD mice reconstituted with a B10.BR/cd hematopoietic cell system remained totally free of insulitis, failed to develop diabetes, and thrived to old age. In contrast, lethally irradiated C57BL/6 or B10.BR/cd mice reconstituted with an NOD hematopoietic cell system all developed insulitis, but only approximately 10% progressed to overt diabetes. Direct adoptive transfer of insulitis and diabetes by mature T-lymphocytes apparently was not required; analogous results were obtained when diabetes-nonsusceptible hosts were reconstituted with NOD hematopoietic cells containing T-lymphocytes or devoid of Thy-1+ cells. The difference in frequency for the development of insulitis versus insulitis plus overt diabetes in C57BL/6 and B10.BR/cd mice suggests that the hematopoietically derived immune cells from NOD mice were sufficient to induce anti-islet reactivity but may require the diabetogenic host environment to develop the frequency and severity of diabetes observed in NOD mice.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2661286     DOI: 10.2337/diab.38.7.894

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  12 in total

1.  Transplantation analysis of B cell destruction in (NOD x CBA)F1 mouse bone marrow chimeras.

Authors:  D V Serreze; E H Leiter; L D Shultz
Journal:  Diabetologia       Date:  1990-02       Impact factor: 10.122

2.  Prevention of adoptively transferred diabetes in nonobese diabetic mice with IL-10-transduced islet-specific Th1 lymphocytes. A gene therapy model for autoimmune diabetes.

Authors:  M Moritani; K Yoshimoto; S Ii; M Kondo; H Iwahana; T Yamaoka; T Sano; N Nakano; H Kikutani; M Itakura
Journal:  J Clin Invest       Date:  1996-10-15       Impact factor: 14.808

3.  Transfusion of nonobese diabetic mice with allogeneic newborn blood ameliorates autoimmune diabetes and modifies the expression of selected immune response genes.

Authors:  Sundararajan Jayaraman; Tejas Patel; Vasu Patel; Shahnaz Ajani; Rebecca Garza; Arathi Jayaraman; Sung Kwon; Rajvir Singh; Damiano Rondelli; Bellur S Prabhakar; Mark Holterman
Journal:  J Immunol       Date:  2010-02-17       Impact factor: 5.422

4.  Transfer of hematopoietic stem cells encoding autoantigen prevents autoimmune diabetes.

Authors:  Raymond J Steptoe; Janine M Ritchie; Leonard C Harrison
Journal:  J Clin Invest       Date:  2003-05       Impact factor: 14.808

5.  Pancreatic NOD beta cells express MHC class II protein and the frequency of I-A(g7) mRNA-expressing beta cells strongly increases during progression to autoimmune diabetes.

Authors:  U Walter; T Toepfer; K E J Dittmar; K Kretschmer; J Lauber; S Weiss; G Servos; O Lechner; W A Scherbaum; S R Bornstein; H Von Boehmer; J Buer
Journal:  Diabetologia       Date:  2003-07-10       Impact factor: 10.122

6.  Prevention of type 1 diabetes by gene therapy.

Authors:  Chaorui Tian; Jessamyn Bagley; Nathalie Cretin; Nilufer Seth; Kai W Wucherpfennig; John Iacomini
Journal:  J Clin Invest       Date:  2004-10       Impact factor: 14.808

7.  Genetic differences in bone marrow-derived lymphoid lineages control susceptibility to experimental autoimmune myocarditis.

Authors:  Haiyan S Li; Davinna L Ligons; Noel R Rose; Mehmet L Guler
Journal:  J Immunol       Date:  2008-06-01       Impact factor: 5.422

8.  Distinct requirements for achievement of allotolerance versus reversal of autoimmunity via nonmyeloablative mixed chimerism induction in NOD mice.

Authors:  Boris Nikolic; Takashi Onoe; Yasuo Takeuchi; Zain Khalpey; Valeria Primo; Igor Leykin; R Neal Smith; Megan Sykes
Journal:  Transplantation       Date:  2010-01-15       Impact factor: 4.939

Review 9.  Induction of tolerance in autoimmune diseases by hematopoietic stem cell transplantation: getting closer to a cure?

Authors:  Richard K Burt; Shimon Slavin; William H Burns; Alberto M Marmont
Journal:  Int J Hematol       Date:  2002-08       Impact factor: 2.319

10.  LINC00115 promotes stemness and inhibits apoptosis of ovarian cancer stem cells by upregulating SOX9 and inhibiting the Wnt/β-catenin pathway through competitively binding to microRNA-30a.

Authors:  Rui Hou; Luo Jiang
Journal:  Cancer Cell Int       Date:  2021-07-08       Impact factor: 5.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.